<p>BHK-ABCA1 cells were plated in 24-well plates and stimulated for 20 h. Cells were then incubated with 2 μg/ml of <sup>125</sup>I-apo A-I for 2 h at 37°C with increasing molar concentrations relative to apo A-I of either CS-6253 peptide, ATI-5261, human apo E, and unlabelled apo A-I (0, 0.0035, 0.017, 0.035, 0.071, 0.17, 0.35, 1.79 μM). Cells were then washed rapidly three times with ice-cold PBS/BSA and then PBS alone. <sup>125</sup>I-apo A-I cell associated was determined as described under “Experimental Procedures.” The values shown represent the mean ± S.D from triplicate wells. The 100% of control value measured in the absence of competitors was 0.21 ng of apo A-I /μg cell protein. Values of IC<sub>50</sub> shown were determined usin...
<p>The peptide binding affinities of the biotinylated HLA-A*0201-HAT-BSP was compared to the standar...
<p>Microtiter plates were coated with various purified human complement proteins or BSA as a negativ...
<p>Competition ELISA to determine the capacity of peptides to block binding of anti-ApoA-I antibodie...
<p>Primary human astrocytes from three donors genotyped for <i>APOE</i> (<i>A</i>) D1: <i>E3/E4</i>,...
<p>A) Binding of Ab from Aß mAb – expressing AAV vector transduced HEK293 cells to synthetic Aß pept...
<p>Non denaturing gradient gel electrophoresis (4–20%) is used to separate CS-6253 complexes, apo A-...
<p>Heparin-immobilized beads (Pierce) were pre-equilibrated with PBS and then incubated with 500 µl ...
<p>(A and B): nHDL-CS-6253 and nHDL-apo A-I released to the medium at specific time points (45 min a...
<p>X: amino-n-butyric acid. ND: not determined. The result is expressed as the mean ± S.D., <i>n</i>...
<div><p>Apolipoprotein (apo) mimetic peptides replicate some aspects of HDL function. We have previo...
<p>A Time course of <sup>125</sup>I-apamin binding to HEK 293 cells stably expressing K<sub>Ca</sub>...
<p>(<b>A&B</b>) HepG2 cells were incubated with 100 µM adenosine diphosphate (ADP) for 24 h in serum...
<p>A Time course of <sup>125</sup>I-apamin binding to HEK 293 cells stably expressing K<sub>Ca</sub>...
<p>(A) ELISA plates were coated with c-myc peptide, purified R5-6 or R5-6C, or null eluent from empt...
Objective—The purpose of this study was to understand the interactions of apoA-I with cells expressi...
<p>The peptide binding affinities of the biotinylated HLA-A*0201-HAT-BSP was compared to the standar...
<p>Microtiter plates were coated with various purified human complement proteins or BSA as a negativ...
<p>Competition ELISA to determine the capacity of peptides to block binding of anti-ApoA-I antibodie...
<p>Primary human astrocytes from three donors genotyped for <i>APOE</i> (<i>A</i>) D1: <i>E3/E4</i>,...
<p>A) Binding of Ab from Aß mAb – expressing AAV vector transduced HEK293 cells to synthetic Aß pept...
<p>Non denaturing gradient gel electrophoresis (4–20%) is used to separate CS-6253 complexes, apo A-...
<p>Heparin-immobilized beads (Pierce) were pre-equilibrated with PBS and then incubated with 500 µl ...
<p>(A and B): nHDL-CS-6253 and nHDL-apo A-I released to the medium at specific time points (45 min a...
<p>X: amino-n-butyric acid. ND: not determined. The result is expressed as the mean ± S.D., <i>n</i>...
<div><p>Apolipoprotein (apo) mimetic peptides replicate some aspects of HDL function. We have previo...
<p>A Time course of <sup>125</sup>I-apamin binding to HEK 293 cells stably expressing K<sub>Ca</sub>...
<p>(<b>A&B</b>) HepG2 cells were incubated with 100 µM adenosine diphosphate (ADP) for 24 h in serum...
<p>A Time course of <sup>125</sup>I-apamin binding to HEK 293 cells stably expressing K<sub>Ca</sub>...
<p>(A) ELISA plates were coated with c-myc peptide, purified R5-6 or R5-6C, or null eluent from empt...
Objective—The purpose of this study was to understand the interactions of apoA-I with cells expressi...
<p>The peptide binding affinities of the biotinylated HLA-A*0201-HAT-BSP was compared to the standar...
<p>Microtiter plates were coated with various purified human complement proteins or BSA as a negativ...
<p>Competition ELISA to determine the capacity of peptides to block binding of anti-ApoA-I antibodie...